Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome

Paride Schito; Tommaso Russo; Teuta Domi; Alessandra Mandelli; Laura Pozzi; Ubaldo Del Carro; Paola Carrera; Federica Agosta; Angelo Quattrini; Roberto Furlan; Massimo Filippi; Nilo Riva

doi:10.1212/wnl.0000000000207223

Related publications

Article2018

Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis

Benjamin Gille, Maxim De Schaepdryver, Janne Goossens, Lieselot Dedeene, Joke De Vocht, Emanuela Oldoni, An Goris, Ludo Van Den Bosch, Bart Depreitere, Kristl G. Claeys, Jos Tournoy, Philip Van Damme, Koen Poesen

Article2022

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis

Yuri Falzone, Teuta Domi, Alessandra Mandelli, Laura Pozzi, Paride Schito, Tommaso Russo, Alessandra Barbieri, Raffaella Fazio, Maria Antonietta Volonté, Giuseppe Magnani, Ubaldo Del Carro, Paola Carrera, Andrea Malaspina, Federica Agosta, Angelo Quattrini, Roberto Furlan, Massimo Filippi, Nilo Riva

Article2009

Structural and metabolic changes in the brain of patients with upper motor neuron disorders: A multiparametric MRI study

Arnaud Charil, Massimo Corbo, Massimo Filippi, Chandrasekharan Kesavadas, Federica Agosta, Elisabetta Munerati, Anna Gambini, Gıancarlo Comı, Giuseppe Scotti, Andrea Falini

Article2018

Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis

Hans‐Peter Müller, Federica Agosta, Martin Gorges, Rebecca Kassubek, Edoardo Gioele Spinelli, Nilo Riva, Albert C. Ludolph, Massimo Filippi, Jan Kassubek

Article2016

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis

Ricarda Menke, Federica Agosta, Julian Großkreutz, Massimo Filippi, Martin R. Turner